Quantitative research revealed that 24 hr after infection, JS2022 dramatically reduced the expression of downstream interferon-stimulated genes and the innate immune factors IFN-β and IFN-λ3 and bovine nasal mucosal explants. This evidence concerns the gene IFNL3 and infection.